Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics

Diabetes Research and Clinical Practice

Volumn 54, Issue 3, 2001, Pages 191-201

  Baba, S ^a,ak   Koike, T ^b   Makino, I ^c   Maruhama, Y ^d   Sasaki, H ^e   Goto, Y ^f   Toyota, T ^g   Fukuchi, S ^h   Shibata, A ⁱ   Hashizume, K ^j   Saito, Y ^k   Saito, T ^l   Mori, M ^m   Kanazawa, Y ^l   Omori, Y ⁿ   Yazaki, Y ^o   Ikeda, Y ^p   Isogai, S ^q   Kajinuma, H ^r   Oikawa, S ^s   Yoshino, G ^t   Yamada, N ^u   Akanuma, Y ^r   Sakai, H ^v   Yoshimi, T ^w   Sakamoto, N ^x   Takeda, Y ^y   Kobayashi, M ^z   Kikkawa, R ^aa   Shigeta, Y ^aa   Nakao, K ^ab   Kita, T ^ab   Kondo, M ^ac   Matsuzawa, Y ^ad   Hanafusa, T ^ae   Inada, M ^af   Harano, Y ^ag   Nanjo, K ^ah   Kasuga, M ^ai   Kazumi, T ^aj   Shima, K ^al   Takahara, J ^am   Hashimoto, K ^an   Nishida, S ^ao   Kato, Y ^ap   Kaneko, T ^aq   Nawata, S ^ar   Umeda, F ^as   Nagataki, S ^at   Nonaka, K ^au   Shichiri, M ^av   Nakashima, M ^aw   Origasa, H ^z   more..

^a Tokiwa Bldg   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d Miyagi Social Insurance Hospital   (Japan)

^e YAMAGATA UNIVERSITY   (Japan)

^f Tohoku Welfare Pension Hospital   (Japan)

^g TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

ⁱ Tachikawa Medical Center Tachikawa General Hospital   (Japan)

^j SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k CHIBA UNIVERSITY   (Japan)

^l JICHI MEDICAL UNIVERSITY   (Japan)

^m GUNMA UNIVERSITY   (Japan)

ⁿ Social Welfare Organization Saiseikai Kurihashi Hospital   (Japan)

^o NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^p TANITA Body Weight Scientific Institute   (Japan)

^q Yamauchi Hospital   (Japan)

^r INSTITUTE FOR ADULT DISEASES   (Japan)

^s NIPPON MEDICAL SCHOOL   (Japan)

^t TOHO UNIVERSITY   (Japan)

^u UNIVERSITY OF TSUKUBA   (Japan)

^v TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^x CHUBU ROSAI HOSPITAL   (Japan)

^y KKR Hokuriku Hospital   (Japan)

^z TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^aa SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^ab KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ac KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^ad OSAKA UNIVERSITY   (Japan)

^ae OSAKA MEDICAL COLLEGE   (Japan)

^af Moriguchi City Health Care Center   (Japan)

^ag KOSHIEN UNIVERSITY   (Japan)

^ah WAKAYAMA UNIVERSITY   (Japan)

^ai KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aj Hyogo Rehabilitation Centre Hospital   (Japan)

^ak International Institute for Diabetes Education and Study   (Japan)

^al Kawashima Hospital   (Japan)

^am KAGAWA UNIVERSITY HOSPITAL   (Japan)

^an KOCHI MEDICAL SCHOOL   (Japan)

^ao KAWASAKI MEDICAL SCHOOL   (Japan)

^ap SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^aq YAMAGUCHI ROSAI HOSPITAL   (Japan)

^ar KYUSHU UNIVERSITY   (Japan)

^as Fukuoka Medical Association Hospital   (Japan)

^at RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^au KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^av Bell Land General Hospital Diabetes Center   (Japan)

^aw Hamamatsu Institute of Clinical Pharmacology and Therapeutics   (Japan)

more..

Author keywords

Cardiovascular event; Enalapril; Hypertensive type 2 diabetics; Nifedipine retard; Urinary albumin excretion rate

Indexed keywords

ALBUMIN; ENALAPRIL; NIFEDIPINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; REMISSION;

ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENALAPRIL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0034750970     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00288-1     Document Type: Article

References (23)

1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
2. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
3. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
4. Standards of medical care for patients with diabetes mellitus
5. National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes
6. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria
7. Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetes associated with hypertension: One year analysis
8. Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients
9. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria
10. Hypertension and non-insulin-dependent diabetes
11. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients
12. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine
13. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure
14. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
15. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM
16. The triumvirate, β-cell, muscle, liver: A collusion responsible for NIDDM
17. Microalbuminuria in diabetes mellitus: Review and recommendations for the measurement of albumin in urine
18. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
19. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study
20. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients
21. Prediction of creatinine clearance from serum creatinine
22. Effect of nifedipine on renal function in patients with essential hypertension
23. The effect of nifedipine GITS on renal function in hypertensive patients with renal insufficiency